The Pharma Content Evolution: Content Reuse and Automation

Help create safe, effective medicines in less time

To help create safe, effective medicines in less time, you must change how you “do” content. You need to harness the power of content reuse and automation. You also need to prepare for digital submissions and AI-based content generation. To do that, you need to move toward a component-based, structured authoring ecosystem based on standards.

In this white paper, we show how content reuse and automation streamlines the end-to-end content journey. We include examples of content reuse opportunities inherent to regulatory content and provide an overview of how to create a reuse strategy that works for you.

What is the pharma content evolution
What is a content reuse strategy
The risks and costs of ‘content drift’
How content reuse and automation directly impact the business
How to create a content reuse strategy

Author
Recent Posts

Val Swisher

Val Swisher is the Founder and CEO of Content Rules, Inc. Val enjoys helping companies solve complex content problems. She is a well-known expert in content strategy, structured authoring, global content, content development, and terminology management. Val believes content should be easy to read, cost-effective to create and translate, and efficient to manage. Her customers include industry giants such as Google, Cisco, Visa, Facebook, Roche, and IBM. Her fourth book, “The Personalization Paradox: Why Companies Fail (and How to Succeed) at Creating Personalized Experiences at Scale,” was published in 2021 by XML Press.

Val is on the Advisory Board for the Technical Communications Program at the University of North Texas. When not working with customers or students, Val can be found sitting behind her sewing machine working on her latest quilt. She also makes a mean hummus.